The histological transformation of NSCLC into SCLC has been reported as an important mechanism of EGFR-TKI-resistance that occurs in 2%–15% of NSCLC patients after EGFR-TKI failure (5). This evidence concerns the gene EGFR and non-small cell lung carcinoma.